Homeadmin2025-10-08T02:58:23+00:00

home graph

homepage graph 2

homepage graph 3

Detection of antigen-specific immunity

Immunogenomic analysis

home graph

home graph

Detection of antigen-specific immunity

home graph

Immunogenomic analysis

Advancing cancer immunotherapy research

State-of the-art technology and systems for molecular and cellular analysis of immune response to cancer therapeutics

Scientific advice and technical support

Advancing cancer immunotherapy research

State-of the-art technology and systems for molecular and cellular analysis of immune response to cancer therapeutics

Scientific advice and technical support

CIO-TIGL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network

Copyright © 2025 Dana-Farber Cancer Institute, Inc. All Rights Reserved

Site developed by Health Communication Core

CIO-TIGL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network

Copyright © 2025 Dana-Farber Cancer Institute, Inc. All Rights Reserved

Site developed by Health Communication Core